Penetrating Aortic Ulcer clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
open to eligible people ages 18 years and up
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.
at UCSD
Our lead scientists for Penetrating Aortic Ulcer research studies include John Lane, M.D..
Last updated: